This excerpt taken from the BAX DEF 14A filed Mar 18, 2009.
Continuing in Office (Term Expires 2011)
Wayne T. Hockmeyer, Ph.D., age 64, has served as a
Director of Baxter since September 2007. Dr. Hockmeyer was
the founder of MedImmune, Inc., a healthcare company focused on
infectious diseases, cancer and inflammatory diseases, and
served as Chairman and/or Chief Executive Officer of MedImmune
from 1988 to 2007. Prior to that, he was vice president of
laboratory research and product development at Praxis Biologics
Inc. and chief of the Department of Immunology at Walter Reed
Army Institute of Research. Dr. Hockmeyer also serves as a
director of Middlebrook Pharmaceuticals, Inc., GenVec Inc. and
Idenix Pharmaceuticals Inc.
Joseph B. Martin, M.D., Ph.D., age 70, has
served as a Director of Baxter since 2002. Dr. Martin
serves as Professor of Neurobiology at Harvard Medical School.
From July 1997 to July 2007, Dr. Martin served as Dean of
the Harvard Faculty of Medicine. He was Chancellor of the
University of California, San Francisco from 1993 to 1997
and Dean of the UCSF School of Medicine from 1989 to 1993. From
1978 to 1989, he was chief of the neurology department of
Massachusetts General Hospital and Professor of Neurology at
Harvard Medical School.
Robert L. Parkinson, Jr., age 58, is Chairman and Chief
Executive Officer of Baxter, having served in that capacity
since April 2004. Prior to joining Baxter, Mr. Parkinson was
Dean of Loyola University Chicagos School of Business
Administration and Graduate School of Business from 2002 to
2004. He retired from Abbott Laboratories in 2001 following a
25-year career, having served in a variety of domestic and
international management and leadership positions, including as
President and Chief Operating Officer. Mr. Parkinson also serves
on the boards of directors of Chicago-based Northwestern
Memorial Hospital and the Northwestern Memorial Foundation as
well as Loyola University Chicagos Board of Trustees.
Thomas T. Stallkamp, age 62, has served as a Director of
Baxter since 2000. Mr. Stallkamp has been an Industrial
Partner in Ripplewood Holdings L.L.C., a New York private
equity group, since 2004. From 2003 to 2004, he served as
Chairman of MSX International, Inc., a global provider of
technology-driven engineering, business and specialized staffing
services, and from 2000 to 2003, he served as Vice-Chairman and
Chief Executive Officer of MSX. From 1980 to 1999, Mr.
Stallkamp held various positions with DaimlerChrysler
Corporation and its predecessor Chrysler Corporation, the most
recent of which was Vice Chairman and President. Mr. Stallkamp
also serves as a director of BorgWarner Inc. and Honsel
International Technologies S.A and a director and non-executive
co-chairman of Asahi Tec Corporation.
Albert P.L. Stroucken, age 61, has served as a Director
of Baxter since 2004. Mr. Stroucken has served as
Chairman, President and Chief Executive Officer of
Owens-Illinois, Inc., a glass packaging company, since 2006 and
as director since 2005. From 1998 to 2006, Mr. Stroucken served
as President and Chief Executive Officer of H.B. Fuller Company,
a manufacturer of adhesives, sealants, coatings, paints and
other specialty chemicals. Mr. Stroucken served as Chairman of
the Board of H.B. Fuller Company from 1999 to 2006. From
1997 to 1998, he was General Manager of the Inorganics Division
of Bayer AG. From 1992 to 1997, Mr. Stroucken was Executive
Vice President and President of the Industrial Chemicals
Division of Bayer Corporation.
Skip the spreadsheet. Track your investments automatically.